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Purpose:Gadolinium-enhancedmagnetic resonance angiography (MRA) is commonly used as a screeningmodality for the
detection of renal artery stenosis. However, evidence supporting its utility in clinical practice is lacking; few rigorous
studies have compared MRA with contrast arteriography (CA). After making anecdotal clinical observations that MRA
sometimes overestimated the degree of renal artery stenosis, we decided to determine the interobserver variability,
sensitivity, specificity, and diagnostic accuracy of MRA compared with CA.
Methods: From September 1999 to April 2003, we evaluated 68 renal arteries in 34 patients with clinically suspected renal
artery stenosis using both MRA and CA. All studies were independently reviewed by four blinded observers. Renal
arteries were categorized by MRA as normal, <50%, and >50% stenosis/occlusion. The sensitivity, specificity, and
accuracy of MRA detection of renal artery stenosis were compared to CA as the gold standard. Interobserver variability
() was also calculated.
Results: MRA demonstrated 87% sensitivity, 69% specificity, 85% accuracy, 95% negative predictive value, and 51%
positive predictive value for the diagnosis of renal artery stenosis. Interobserver agreement was moderate for MRA ( 
0.53) and good for CA (  0.76). In 21 arteries (31%), MRA was falsely positive.
Conclusions: In patients with a high clinical suspicion of renal artery stenosis, MRA is 87% sensitive in the detection of
>50% stenosis. However, MRA is relatively nonspecific compared with CA and results in significant overestimation of
renal artery stenosis in nearly one third of patients. To reduce unnecessary CA, clinicians should consider supplemental
studies. ( J Vasc Surg 2005;41:462-8.)Renal artery stenosis is a clinically significant problem
with an estimated prevalence of 1% to 3% among all patients
with arterial hypertension.1,2 However, as many as 40% of
hypertensive patients who are refractory to medical therapy
may harbor significant renal artery stenosis.3 Contrast arte-
riography (CA) is the diagnostic gold standard, but its
invasiveness, expense, and attendant risks make it unsuit-
able as a screening test.
As therapy for renal artery stenosis has improved with
the availability of lower-profile introducer, catheter, guide-
wire, angioplasty, and stent technology, the need for an
accurate, less-invasive screening test for renal artery stenosis
has assumed greater importance. The goals of such a
screening test are to reliably detect those patients with
hemodynamically significant renal artery stenosis who
could potentially benefit from CA and either percutaneous
transluminal angioplasty (with or without stent) or bypass
while excluding those individuals with normal renal arteries
for whom contrast CA would be unnecessary.
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462A wide array of noninvasive tests such as duplex ultra-
sonography scanning, renal scintigraphy before and after
captopril administration, computed tomographic angiog-
raphy, and magnetic resonance angiography (MRA) have
been proposed as screening tests for renal artery stenosis,
but their relative merits have not been established, and their
use seems to be determined primarily by local practice
patterns.
Duplex ultrasonography scanning has high sensitivity and
specificity in experienced hands; however, it can be tedious
and time-consuming, is highly operator-dependent, does not
reliably visualize accessory ormultiple renal arteries, and 8% to
15% of exams are nondiagnostic.4-7
Renal scintigraphy has never been widely accepted. The
test protocols are complex and diagnostic criteria are not
well standardized.8,9 Scintigraphy was also recently shown
to be of limited use in populations with a low prevalence of
renovascular disease.10 Because of the inadequacy of these
screening tests, a relatively high proportion of patients may
therefore be subjected to CA that turns out to be normal.
The introduction of three-dimensional (3D) contrast-
enhanced MRA (CE-MRA) has resulted in the increasing
use of this technology as a screening test for renal artery
stenosis. Potential advantages of gadolinium-enhanced
MRA over CA include intravenous rather than intra-arterial
contrast administration, lack of ionizing radiation, low risk
of nephrotoxicity, no need for supervised recovery after the
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as hematoma, pseudoaneurysm, and atheroembolism.
All these advantages make CE-MRA a potentially at-
tractive screening method for patients with suspected renal
artery stenosis. CE-MRA was first described by Prince et al
in 1993.11 It provides anatomic images that are similar to
CA and also offers the advantage of multiplanar reformat-
ting. High-performance MR gradient systems now allow
acquisition of 3D volumes in a single-breath hold 30
seconds rendering renal artery images with excellent spatial
resolution.12-14 CE-MRA may be more accurate than CA
owing to multiplanar reconstruction capabilities. At CA,
eccentric stenoses may be underestimated because of the
limited number of planes of projection.15,16 Also in the case
of a tortuous aorta, the origins of the renal arteries may be
difficult to visualize.
CE-MRA, however, is not without its own potential
limitations. Complex regional blood-flow disturbances
may result in signal loss and subsequent overestimation of
both the length and degree of stenosis.17-19 In addition,
several clinical reports have suggested that CE-MRA for
renal artery stenosis has a rather high interobserver variabil-
ity.20-22
In our tertiary care vascular practice, patients suspected
of having renal artery stenosis often undergo CE-MRA
before referral to our service for further management. Our
anecdotal experience suggested that CE-MRA not infre-
quently overestimated the degree of renal artery stenosis
compared with CA. A preliminary review of the literature
revealed a relative lack of rigorous clinical studies compar-
ing the accuracy of CE-MRA to CA in the evaluation of
patients suspected of having renovascular hypertension.We
conceived the present study to evaluate the sensitivity,
specificity, accuracy, and interobserver and intermodality
variability of CE-MRA compared with CA in the determi-
nation of the presence and degree of renal artery stenosis in
patients undergoing evaluation for renovascular hyperten-
sion using four blinded observers.
METHODS
The findings in 34 patients who underwent both CA
and gadolinium-enhanced 3D MRA (CE-MRA) at the
University Medical Center, Tucson, Arizona), between
September 1999 and April 2003 were retrospectively re-
viewed. The decision to obtain renal artery imaging was
made on clinical grounds by either the referring physician
or the vascular surgery attending. Suspicion of renal artery
stenosis was based primarily on the presence of new onset
or medically refractory hypertension or unexplained renal
insufficiency.
Study techniques. CE-MRA was performed on a 1.5
Tesla machine (Siemens, Erlangen, Germany) using a
phased-array body coil. The pulse sequence used for MRA
was a coronal spoiled gradient-echo acquisition with a
repetition time of 4.7 milliseconds, an echo time of 2.1
milliseconds, a flip angle of 50°, and a 256  160 matrix.
Partition thickness and field of view were adjusted to pa-tient body habitus and ranged from 1.6 to 2 mm and 30 to
38 cm, respectively.
The data were acquired in a breath-hold interval lasting
27 seconds timed to coincide with the arterial phase of a
dynamic bolus of 0.3 mmol/kg body weight of gadolinium
diethylene triamine penta-acetic acid infused at 0.3 mL/s.
The timing protocol determined from the contrast travel
time from the antecubital venous injection site to the
abdominal aorta using a 2-mL test bolus.
GE Medical Systems postprocessing software was uti-
lized and included maximum intensity projections and 3D
multiplanar reformations. The former is an algorithm that
allows display of a 3D volume of image data as a 2D
projection and renders images similar to those of CA. The
3D multiplanar reformations, the more important tech-
nique, allow the user to view the 3D imaging volume in
cross section in any desired plane. Maximum intensity
projections of the source phase-contrast images were gen-
erated by scanner software.
CA was performed with the Seldinger technique via a
percutaneous femoral approach using a 5F pigtail catheter
introduced into the abdominal aorta just above the level of
the renal arteries. Intra-arterial, nonionic contrast material
was injected (volume 30 to 40 mL; injection rate,
15 to 20 mL/s; frame rate 2/sec). Imaging was initially
performed in the posteroanterior projection. Multiple in-
jections with different projections, magnification views,
and selective runs were performed as required.
CA was performed from 1 day to 5 months after MRA
(mean, 45 days). The techniques for CE-MRA and CA
were consistent over the study period.
Methodology of renal artery stenosis determina
tion. Four readers (STP, JLM, GTC, KRG) independently
assessed the CA andMRA images to calculate the degree of
renal artery stenosis. Only the main renal arteries were
assessed. Each reader was blinded to the clinical data and to
each other’s interpretations. Observers were also not aware
of CA findings when they analyzed MRA findings and vice
versa.
Image analysis was based on original CE-MRA data
sets, maximum intensity projections reconstructions, and
CA. The degree of renal artery stenosis was graded as a
percentage of the luminal diameter. Maximal stenosis was
determined by comparing the narrowest diameter within
the stenosis (SD) and the diameter of the nearest down-
stream normal diameter (ND) segment of the main renal
artery [% stenosis  (ND – SD)/ND 100].
When vessel branching or poststenotic dilatation pre-
cluded precise measurement of a normal distal renal artery
segment, the nearest normal upstream renal artery segment
was used to make an estimate. When two or more stenoses
were identified in a single renal artery, the most severe
stenosis was used for grading and analysis.
The degree of renal artery stenosis was graded by each
reader by using the projection that demonstrated the max-
imal stenosis: normal, 50% stenosis, and 50% stenosis/
occlusion. We used an approach similar to that of Hany
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The quality of each study was rated as adequate or
inadequate by each observer on the basis of technical ade-
quacy and the presence of significant motion artifacts. The
mean value of all four observers derived from CA was the
standard of reference. The Cohen  statistic, including 95%
confidence intervals (CI), was then determined for each
pair-wise comparison between the four readers.24 The 
values for interobserver agreement were assessed for both
CE-MRA and CA. Typically,  values 0.4 indicate poor
agreement; 0.4 to 0.7 indicate good agreement; and0.75
indicate excellent agreement. The sensitivity and specificity
for renal artery stenosis detection were calculated for CE-
MRA on the basis of findings at CA using a50% threshold
for hemodynamically significant renal artery stenosis. All
statistical analyses were performed with Statistical Package
for the Social Sciences (SPSS) software for Windows ver-
sion 9.0 (SPSS, Chicago, Ill).
Three months after initial assessment, two observers
(STP and GTC) used the same protocol to review the
studies a second time to determine intraobserver variability.
No information from the first assessment was available to
the observers at this time.
RESULTS
The study group consisted of 22 men and 12 women
with a mean age of 54 years (range, 37 to 85). Suspicion of
renal artery stenosis was based on refractory hypertension
(63%) or unexplained renal insufficiency (37%). The patient
group had a high rate of vascular comorbidities and risk
factors such as diabetes mellitus (53%), symptomatic pe-
ripheral arterial disease (63%), hyperlipidemia (55%), and
cigarette smoking (59%). The prevalence of 50% renal
artery stenosis or occlusion in our patient cohort was 73%.
Images were considered of high quality in 98% of CA
and 83% of MRA studies. Poor-quality MRAs were noted
in 17% of patients; in the latter subgroup, best possible
estimates of the degree of renal artery stenosis were made
based on the available reconstructed images.
Overall, MRA demonstrated an 87% sensitivity, 69%
specificity, 85% accuracy, 51% positive predictive value, and
95% negative predictive value for the diagnosis of 50%
renal artery stenosis (Table I). If poor-quality MRAs were
excluded,MRA demonstrated an 84% sensitivity, 74% spec-
ificity, 82% accuracy, 57% positive predictive value, and 92%
negative predictive value for the diagnosis of 50% renal
artery stenosis. Interobserver agreement (Table II) was
good for MRA (  0.53 [95% CI, 0.42 to 0.82]) and
excellent for CA (  0.76 [95% CI, 0.56 to 0.91]).
For the clinically important determination of 50%
renal artery stenosis, MRA was falsely positive in 21 arteries
(31%). For 42 (62%) of 68 individual main renal arteries, all
four readers of MRA’s were in perfect agreement. In com-
parison, for CA, there was perfect interobserver concor-
dance for 74% of the vessels. Four patients had renal artery
occlusion. All four readers were in agreement with thediagnosis of renal artery occlusion, both when interpreting
MRA images as well as for CA studies.
Three months after the initial assessment, the studies
were reviewed a second time by two observers (STP and
GCT) using the same protocol. The intraobserver  for
MRA for observer 1 and 2 were 0.75 (95% CI, 0.44 to
0.89) and 0.80 (95%CI, 0.62 to 0.95). The intraobserver 
for CA for observer 1 and 2 were 0.83 (95% CI, 0.54 to
0.93) and 0.92 (95% CI, 0.74 to 0.98).
DISCUSSION
The widespread availability of MRA has led to its in-
creasing use in the evaluation of patients with peripheral
arterial disease, not only for those who present with sus-
pected cerebrovascular and lower extremity occlusive dis-
ease but also for patients with possible visceral or renal
artery stenosis. Images are generated that are familiar to the
clinician and are quite similar to those obtained by CA.15,16
Despite its ongoing evolution, our impression was that one
of the limitations of CE-MRA as currently performed was
its tendency to overestimate the degree of stenosis in pa-
tients with lesions of moderate severity.
We therefore evaluated 68 renal arteries in 34 patients
and determined that CE-MRA had an 87% sensitivity and a
95% negative predictive value in the detection of a 50%
renal artery stenosis. However, CE-MRA was relatively
nonspecific compared with CA and resulted in significant
overestimation of the degree of renal artery stenosis in 31%
of patients (Figs 1 and 2).
Available studies have reported variable results in the
Table I. Sensitivity, specificity, positive predictive value,
and negative predictive value of CE-MRA compared to
CA in different observers
Observer Sensitivity Specificity PPV NPV
Observer 1 87 68 53 97
Observer 2 90 64 49 96
Observer 3 75 71 56 93
Observer 4 95 73 54 91
Pooled data* 87 69 53 94
CE-MRA, Contrast-enhanced magnetic resonance angiography; CA, con-
trast arteriography; PPV, positive predictive value;NPV, negative predictive
value.
*Mean value of all four observers.
Table II. Interobserver variability for CA and MRA
Observer pairs  CA MRA
Observer 1 vs observer 2 0.81 0.65
Observer 1 vs observer 3 0.75 0.46
Observer 1 vs observer 4 0.82 0.52
Observer 2 vs observer 3 0.78 0.53
Observer 2 vs observer 4 0.74 0.51
Observer 3 vs observer 4 0.76 0.57
Mean value 0.76 0.53
CA, Contrast arteriography; MRA, magnetic resonance angiography.evaluation of CE-MRA to determine the presence of renal
of th
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of 50% renal artery stenosis have ranged from 67% to
100% and 76% to 95%.25-33 A recent meta-analysis of 499
patients who underwent CE-MRA and CA reported that
the sensitivity and specificity of MRA were 97% and 93%
respectively.34 Other investigators have also identified the
problem of overestimation of renal artery stenosis by CE-
MRA compared with CA; this problem has been noted in
26% to 32% of patients in multiple clinical series, primarily
in the radiology literature.18-20
Several alternatives to CE-MRA are available for the
noninvasive evaluation of suspected renal artery stenosis.
Renal duplex is an established noninvasive method for the
detection of renal artery stenosis in many institu-
tions.6,35-39 Duplex criteria for significant renal artery ste-
nosis include renal artery peak systolic velocity (PSV)180
Fig 1. A, Magnetic resonance angiography (MRA) d
Contrast arteriography in the same patient indicates 50
the left renal artery. MRA overestimated the significance
Fig 2. A,Magnetic resonance angiography indicates hi
arteriography indicates a normal left renal artery.cm/sec, renal PSV 200 cm/sec, and a renal artery-to-aortic velocity ratio3.5; two recent reports demonstrated
that a PSV 180 to 200 cm/s reliably indicated a 60%
stenosis with 90% sensitivity.38,39
The resistive index has proved to be a highly valuable
parameter for the prediction of patient improvement after
percutaneous transluminal angioplasty.40 Renal duplex
scanning is limited, however, by an inherent operator-
dependence, a technical failure rate of 10% to 20%, and the
inability to visualize accessory renal arteries. The specificity
and sensitivity of ultrasonography scanning is reportedly
lower than either CA or CE-MRA.4-7 De Cobelli et al31
and Leung et al30 compared CE-MRA and duplex scanning
and reported greater sensitivity for CE-MRA than for du-
plex imaging.
Nuclear imaging (renal scintigraphy) in conjunction
with angiotensin-converting enzyme inhibition provides
nstrates bilateral high-grade renal artery stenoses. B,
nosis of the right renal artery and high-grade stenosis of
e right renal artery lesion.
ade stenosis of the left renal artery. B, Selective contrastemo
% stegh-grvaluable information regarding differential function. How-
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limitations occur in the assessment of patients with renal
impairment, bilateral renal artery stenosis, and intrarenal
disease. Computed tomographic angiography is minimally
invasive and has a high negative predictive value but re-
quires a high contrast load. These and other limitations will
likely limit the widespread use of such techniques for renal
artery screening.
One advantage of CE-MRA is that it can produce
multiplanar images quite comparable to standard CA. Gad-
olinium is also not nephrotoxic and accessory and multiple
renal arteries are more adequately visualized with CE-MRA
than duplex ultrasound scanning.30 However, MR studies
cannot be performed on patients with implanted pacemak-
ers, certain metallic stents, or other metallic devices such as
hip prostheses; patient cooperation and claustrophobia can
also present problems. As demonstrated in the present
study, renal MRA as currently performed still suffers from
the disadvantage of overestimation of moderate stenoses.
The accuracy of CE-MRA interpretation depends on the
sophistication of the image reconstruction software and the
facility with which a radiologist can manipulate images
Fig 3. A, Magnetic resonance angiography (MRA) ind
suggestive of fibromuscular dysplasia. B, Contrast arterio
renal artery. C, A multiplanar reconstruction of the MR
artery.using that software. As software improves, it is likely thatthe problem of stenosis overestimation will be overcome
(Fig 3).
Another advantage of CE-MRA is that not only mor-
phologic data can be acquired but also functional informa-
tion of blood flow and perfusion. Newer MRA applications
identify changes in blood flow, flow pattern, and renal
tissue perfusion.41,42 A multicenter trial has shown that
flow profile evaluation with CE-MRA significantly reduced
interobserver variability and improved overall accuracy
compared to CA, with sensitivities and specificities exceed-
ing 95%.43 Several papers have reported poor interobserver
agreement for both CA and CE-MRA.8,20 Such variability
can be explained in part because precise measurement of
the degree of stenosis is influenced by both interobserver
subjectivity as well as variable interpretations of the mea-
surement criteria (Table III).
The present report suggests that CE-MRAmay have an
increasingly important role in the detection of hemody-
namically significant renal artery stenosis. It is sensitive in
the detection of 50% renal artery stenosis. Its major
limitation is overestimation of the significance of moderate
lesions, a problem that occurred in 31% of cases in the
irregularities of the distal third of the right renal artery
y of the same artery indicates an essentially normal right
icates the lack of significant stenoses of the right renalicates
graph
A indpresent report. Until this limitation is overcome, physicians
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Volume 41, Number 3 Patel et al 467should perform CA before intervention for renal artery
stenosis.
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